Autonomous push button-controlled rapid insulin release from a piezoelectrically activated subcutaneous cell implant


Loading...

Date

2022-06-17

Publication Type

Journal Article

ETH Bibliography

yes

Citations

Altmetric

Data

Abstract

Traceless physical cues are desirable for remote control of the in situ production and real-time dosing of biopharmaceuticals in cell-based therapies. However, current optogenetic, magnetogenetic, or electrogenetic devices require sophisticated electronics, complex artificial intelligence-assisted software, and external energy supplies for power and control. Here, we describe a self-sufficient subcutaneous push button-controlled cellular implant powered simply by repeated gentle finger pressure exerted on the overlying skin. Pushing the button causes transient percutaneous deformation of the implant's embedded piezoelectric membrane, which produces sufficient low-voltage energy inside a semi-permeable platinum-coated cell chamber to mediate rapid release of a biopharmaceutical from engineered electro-sensitive human cells. Release is fine-tuned by varying the frequency and duration of finger-pressing stimulation. As proof of concept, we show that finger-pressure activation of the subcutaneous implant can restore normoglycemia in a mouse model of type 1 diabetes. Self-sufficient push-button devices may provide a new level of convenience for patients to control their cell-based therapies.

Publication status

published

Editor

Book title

Volume

8 (24)

Pages / Article No.

Publisher

AAAS

Event

Edition / version

Methods

Software

Geographic location

Date collected

Date created

Subject

Organisational unit

03694 - Fussenegger, Martin / Fussenegger, Martin check_circle

Notes

Funding

Related publications and datasets